Reuters logo
BRIEF-Cancer Prevention Pharmaceuticals receives $9.5 mln in additional funding from Sucampo
September 11, 2017 / 12:48 PM / 8 days ago

BRIEF-Cancer Prevention Pharmaceuticals receives $9.5 mln in additional funding from Sucampo

Sept 11 (Reuters) - Sucampo Pharmaceuticals Inc:

* Cancer Prevention Pharmaceuticals receives $9.5 million in additional funding from sucampo following phase 3 trial progress

* ‍cancer Prevention Pharmaceuticals - Sucampo paid CPP $4.5 million in option fees and invested $5.0 million in cpp via a convertible note​

* ‍cancer Prevention Pharmaceuticals - received total of $9.5 million from its North America commercialization partner Sucampo Pharmaceuticals Inc.​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below